4.6 Article

Role of 5-HT1A and 5-HT2C receptors of the dorsal periaqueductal gray in the anxiety- and panic-modulating effects of antidepressants in rats

Journal

BEHAVIOURAL BRAIN RESEARCH
Volume 404, Issue -, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.bbr.2021.113159

Keywords

Panic; Anxiety; Serotonin; Dorsal periaqueductal gray; Imipramine; Fluoxetine

Funding

  1. Research Foundation of the State of Sao Paulo (FAPESP) [2017/184377, 2018/001535]
  2. National Council of Science and Technology, Brazil (CNPq)
  3. Coordination for the Improvement of Higher Education Personnel (CAPES)

Ask authors/readers for more resources

Antidepressant drugs are effective in treating panic disorder, with facilitation of 5-HT1A receptors in the dPAG implicated in panic relief. The panicolytic effect caused by chronic administration of ADs may be related to 5-HT1A receptor-mediated neurotransmission, while the anxiogenic effect of short-term treatment with these drugs may not depend on 5-HT2C receptors.
Antidepressant drugs are first-line treatment for panic disorder. Facilitation of 5-HT1A receptor-mediated neurotransmission in the dorsal periaqueductal gray (dPAG), a key panic-associated area, has been implicated in the panicolytic effect of the selective serotonin reuptake inhibitor fluoxetine. However, it is still unknown whether this mechanism accounts for the antipanic effect of other classes of antidepressants drugs (ADs) and whether the 5-HT interaction with 5-HT2C receptors in this midbrain area (which increases anxiety) is implicated in the anxiogenic effect caused by short-term treatment with ADs. The results showed that previous injection of the 5-HT1A receptor antagonist WAY-100635 in the dPAG blocked the panicolytic-like effect caused by chronic systemic administration of the tricyclic AD imipramine in male Wistar rats tested in the elevated T-maze. Neither chronic treatment with imipramine nor fluoxetine changed the expression of 5-HT1A receptors in the dPAG. Treatment with these ADs also failed to significantly change ERK1/2 (extracellular-signal regulated kinase) phosphorylation level in this midbrain area. Blockade of 5-HT2C receptors in the dPAG with the 5-HT2C receptor antagonist SB-242084 did not change the anxiogenic effect caused by a single acute injection of fluoxetine or imipramine in the Vogel conflict test. These results reinforce the view that the facilitation of 5-HT1A receptor mediated neurotransmission in the dPAG is a common mechanism involved in the panicolytic effect caused by chronic administration of ADs. On the other hand, the anxiogenic effect observed after short-term treatment with these drugs does not depend on 5-HT2C receptors located in the dPAG.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available